David Zhang is the founder of NuProbe. NuProbe has raised $110M in total funding. Backed by BioTrack Capital, Yonghua Capital, Taifu Capital.
David Zhang is associated with NuProbe, a genomics and molecular diagnostics company focused on ultrasensitive sequencing panels. NuProbe commercializes a Wyss Institute DNA nanotechnology-based variant-detecting method for low-cost, multiplexed molecular diagnostics.
Full founder directory · Investor directory · Company funding database · Fundraising library